摘要 |
This invention relates to the stabilisation of ifosfamide solutions used in the treatment of tumours as parenteral infusion solutions. In particular, there is provided a liquid pharmaceutical composition for parenteral administration comprising ifosfamide, solvent and optionally, conventional pharmaceutical carriers and excipients, wherein said solvent comprises 35-75 % lower alcohol (based on the total weight of the solvent) and 25-65 % polyol (based on the total weight of the solvent). Said composition is preferably stable at refrigeration temperatures and higher for at least 30 days and more preferably at least 180 days. The polyol solvent is preferably propylene glycol, glycerol and/or polyethylene glycol of MW 200-600. The lower alcohol solvent is preferably ethanol.
|
申请人 |
DBL AUSTRALIA PTY LTD;TAIT, RUSSELL;MURPHY, ANNETTE;DAVEY, GREG;WHITTAKER, DARRYL;YE, YUERONG |
发明人 |
TAIT, RUSSELL;MURPHY, ANNETTE;DAVEY, GREG;WHITTAKER, DARRYL;YE, YUERONG |